孕早期母体甲状腺功能与儿童注意缺陷多动障碍的个体参与数据荟萃分析
该研究纳入三个前瞻性出生队列共7669对母子,分析孕18周内母体TSH、fT4与儿童ADHD的关联。总体233名(3%)儿童符合ADHD标准,连续分析未发现fT4或TSH与ADHD风险升高相关。仅在孕早期观察到较高fT4与症状评分高于第90百分位相关,但该效应按孕周分层不一致,结论为无明确关联证据。
要点
- 连续分析中母体fT4与TSH均与儿童ADHD风险无显著关联。
- 仅孕早期较高fT4与ADHD症状评分高于第90百分位相关(每1 SD:OR 1.2,95%CI 1.0-1.4,p=0.027)。
- 按孕周的差异效应不一致,未观察到性别效应修饰。
核心结论
- 研究未发现母体甲状腺功能与儿童ADHD之间存在明确关联证据。
研究设计与样本
- 三个前瞻性人群出生队列的个体参与数据荟萃分析,共7669对母子(INMA 1073对、Generation R 3812对、ALSPAC 2784对)。
- 排除多胎妊娠、助孕治疗、使用影响甲状腺药物及既往甲状腺疾病者。
- 采用逻辑回归分析母体甲状腺功能与ADHD的关联,ADHD由父母和/或教师按DSM-IV标准评估,儿童中位年龄4.5至7.6岁。
主要发现
- 共233名(3%)儿童符合ADHD标准。
- 连续分析中fT4与ADHD风险关联OR 1.1(95%CI 1.0-1.3,p=0.060),TSH为OR 0.9(95%CI 0.9-1.1,p=0.385)。
- 孕早期较高fT4与症状评分高于第90百分位相关(每1 SD:OR 1.2,95%CI 1.0-1.4,p=0.027),但按孕周的差异效应不一致。
- 未观察到性别对效应的显著修饰。
临床怎么用
- 对孕期甲状腺功能的常规筛查与处理仍应遵循现行指南,本研究不提示需因ADHD风险调整孕期甲状腺功能管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid hormone is essential for optimal fetal brain development. Evidence suggests that both low and high maternal thyroid hormone availability may have adverse effects on child neurodevelopmental outcomes, but the effect on behavioral problems remains unclear. We studied the association of maternal thyrotropin (TSH) and free thyroxine (fT4) concentrations during the first 18 weeks of pregnancy with child attention-deficit hyperactivity disorder (ADHD). Methods: A total of 7669 mother-child pairs with data on maternal thyroid function and child ADHD were selected from three prospective population-based birth cohorts: INfancia y Medio Ambiente (INMA; N = 1073, Spain), Generation R (N = 3812, The Netherlands), and Avon Longitudinal Study of Parents and Children (ALSPAC; N = 2784, United Kingdom). Exclusion criteria were multiple pregnancy, fertility treatment, usage of medication affecting the thyroid, and pre-existing thyroid disease. We used logistic regression models to study the association of maternal thyroid function with the primary outcome, ADHD, assessed via the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria by parents and/or teachers at a median child age of 4.5 to 7.6 years, and with the secondary outcome, an ADHD symptom score above the 90th percentile. Effect modification by gestational age and sex was tested with interaction terms and stratified analyses. Results: Overall, 233 (3%) children met the criteria for ADHD. When analyzed continuously, neither fT4 nor TSH was associated with a higher risk of ADHD (odds ratio [OR] 1.1, 95% confidence interval [CI 1.0-1.3], p = 0.060 and OR 0.9 [CI 0.9-1.1], p = 0.385, respectively) or with high symptom scores. When investigating effect modification by gestational age, a higher fT4 was associated with symptoms above the 90th percentile but only in the first trimester (for fT4 per 1 SD: OR 1.2 [CI 1.0-1.4], p = 0.027). However, these differential effects by gestational age were not consistent. No significant effect modification by sex was observed. Conclusions: We found no clear evidence of an association between maternal thyroid function and child ADHD.
引用
- Levie D, Korevaar TIM, Mulder TA, et al. Maternal Thyroid Function in Early Pregnancy and Child Attention-Deficit Hyperactivity Disorder: An Individual-Participant Meta-Analysis. Thyroid. 2019. PMID: 31426724. doi:10.1089/thy.2018.0794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。